Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.68 |
| ▸ | MEN1 | O00255 | 4/20 | 0.68 |
| ▸ | GAA | P10253 | 1/20 | 0.65 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.63 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.63 |
| ▸ | POLB | P06746 | 1/20 | 0.61 |
| ▸ | IGF1R | P08069 | 2/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.55 |
| ▸ | ATM | Q13315 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1460360 | 1.00 | KDM4E (0.71) | KDM4EKMT2AMEN1GAAOPRM1 | |
| SCHEMBL17835877 | 1.00 | KDM4E (0.71) | KDM4EKMT2AMEN1GAAOPRM1 | |
| SCHEMBL2796836 | 0.87 | GAA (0.82) | KDM4EKMT2AMEN1GAAOPRM1 | |
| SCHEMBL10746494 | 0.87 | GAA (0.82) | KDM4EKMT2AMEN1GAAOPRM1 | |
| SCHEMBL1460325 | 0.85 | MEN1 (0.57) | KDM4EKMT2AMEN1GAAOPRM1 | |
| SCHEMBL31419975 | 0.84 | KDM4E (0.73) | KDM4EKMT2AMEN1GAAOPRM1 | |
| SCHEMBL3082979 | 0.83 | GAA (0.71) | KDM4EKMT2AMEN1GAAOPRM1 | |
| SCHEMBL6979453 | 0.83 | GAA (0.71) | KDM4EKMT2AMEN1GAAOPRM1 | |
| SCHEMBL1205842 | 0.83 | GAA (0.71) | KDM4EKMT2AMEN1GAAOPRM1 | |
| SCHEMBL18587348 | 0.83 | KDM4E (0.71) | KDM4EKMT2AMEN1GAAOPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11130734-B2 | Amino alcohol-boron-binol complex and method for preparing optically active amino alcohol derivative by using same | MOLECULES & MATERIALS CO., LTD. (KR) | 2021-09-28 | — | — | US | disclosed |
| US-11130734-B2 | Amino alcohol-boron-binol complex and method for preparing optically active amino alcohol derivative by using same | MOLECULES & MATERIALS CO., LTD. (KR) | 2021-09-28 | — | — | US | disclosed |
| US-20210206719-A1 | AMINO ALCOHOL-BORON-BINOL COMPLEX AND METHOD FOR PREPARING OPTICALLY ACTIVE AMINO ALCOHOL DERIVATIVE BY USING SAME | MOLECULES & MATERIALS CO., LTD. (KR) | 2021-07-08 | — | — | US | disclosed |
| US-20210206719-A1 | AMINO ALCOHOL-BORON-BINOL COMPLEX AND METHOD FOR PREPARING OPTICALLY ACTIVE AMINO ALCOHOL DERIVATIVE BY USING SAME | MOLECULES & MATERIALS CO., LTD. (KR) | 2021-07-08 | — | — | US | disclosed |
| CN-113072486-A | Amino alcohol-boron-binaphthol complex and preparation method of optically active amino alcohol derivative using same | 分子与物质株式会社 | 2021-07-06 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11130734-B2 | Amino alcohol-boron-binol complex and method for preparing optically active amino alcohol derivative by using same | BCAT1, BCAT2, HBS1L | KDM4E 3777/4885KMT2A 3665/4885MEN1 924/4885 |
| US-20210206719-A1 | AMINO ALCOHOL-BORON-BINOL COMPLEX AND METHOD FOR PREPARING OPTICALLY ACTIVE AMINO ALCOHOL DERIVATIVE BY USING SAME | BCAT1, BCAT2, HBS1L | KDM4E 3506/4885KMT2A 3481/4885MEN1 1024/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.